Federico AD - Search Results

1

Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: rationale and clinical implication.

Lamberti G, Andrini E, Sisi M, Federico AD, Ricciuti B. Lamberti G, et al. Among authors: federico ad. Future Oncol. 2020 Aug;16(23):1751-1766. doi: 10.2217/fon-2020-0215. Epub 2020 Jun 15. Future Oncol. 2020. PMID: 32539551 Review.

2

Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges.

Rizzo A, Federico AD, Ricci AD, Frega G, Palloni A, Pagani R, Tavolari S, Marco MD, Brandi G. Rizzo A, et al. Among authors: federico ad. Cancer Control. 2020 Jan-Dec;27(1):1073274820983013. doi: 10.1177/1073274820983013. Cancer Control. 2020. PMID: 33356500 Free PMC article. Review.

3

Dual immune checkpoint blockade in hepatocellular carcinoma: where do we stand?

Carloni R, Rizzo A, Ricci AD, Frega G, Federico AD, Palloni A, Marco MD, Gadaleta-Caldarola G, Brandi G. Carloni R, et al. Among authors: federico ad. Future Oncol. 2022 Mar;18(8):1023-1034. doi: 10.2217/fon-2021-0905. Epub 2022 Feb 3. Future Oncol. 2022. PMID: 35109664 Review.

4

Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies.

Andrini E, Federico AD, Sisi M, Rosellini M, Palladini A, Lamberti G, Giglio A, Gelsomino F. Andrini E, et al. Among authors: federico ad. Immunotherapy. 2022 Nov;14(16):1329-1340. doi: 10.2217/imt-2022-0060. Epub 2022 Nov 16. Immunotherapy. 2022. PMID: 36382476 Review.

5

Advances in novel systemic therapies for advanced hepatocellular carcinoma.

Carloni R, Rizzo A, Cusmai A, Palloni A, Federico AD, Marco MD, Massafra R, Fanizzi A, Palmiotti G, Brandi G. Carloni R, et al. Among authors: federico ad. Future Med Chem. 2022 Oct;14(20):1455-1470. doi: 10.4155/fmc-2022-0045. Epub 2022 Aug 23. Future Med Chem. 2022. PMID: 35997677 Review.

6

Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine.

Carloni R, Rizzo A, Ricci AD, Federico AD, De Luca R, Guven DC, Yalcin S, Brandi G. Carloni R, et al. Among authors: federico ad. Transl Oncol. 2022 Nov;25:101514. doi: 10.1016/j.tranon.2022.101514. Epub 2022 Aug 14. Transl Oncol. 2022. PMID: 35977458 Free PMC article. Review.

7

Eosinophilic folliculitis of the scalp associated with PD-1/PDL1 inhibitors.

Rossi A, Magri F, Caro G, Federico A, Fortuna MC, Soda G, De Vincentiis L, Carlesimo M. Rossi A, et al. J Cosmet Dermatol. 2020 Dec;19(12):3367-3370. doi: 10.1111/jocd.13388. Epub 2020 Apr 12. J Cosmet Dermatol. 2020. PMID: 32281235

8

Should We Test Cancer Susceptibility Genes in Routinely Used Multigene Panels? A Case of Synchronous Lung Adenocarcinoma and Breast Cancer Associated With Germline CHEK2 Mutation.

Federico AD, Gelsomino F, De Biase D, Ardizzoni A. Federico AD, et al. Clin Lung Cancer. 2022 Jun;23(4):e283-e284. doi: 10.1016/j.cllc.2021.09.011. Epub 2021 Oct 10. Clin Lung Cancer. 2022. PMID: 34772625 No abstract available.

9

The management of pseudomyogenic hemangioendothelioma of the foot: A case report and review of the literature.

Pranteda G, Magri F, Muscianese M, Pigliacelli F, D'Arino A, Federico A, Pranteda G, Bartolazzi A. Pranteda G, et al. Dermatol Ther. 2018 Nov;31(6):e12725. doi: 10.1111/dth.12725. Epub 2018 Sep 21. Dermatol Ther. 2018. PMID: 30239066 Review.

10

Kerion mimicking an erosive pustular dermatosis of the scalp.

Magri F, Pranteda G, Federico A, Muscianese M, Pigliacelli F, D'arino A, Paolino G, Bottoni U, Pranteda G. Magri F, et al. G Ital Dermatol Venereol. 2019 Feb;154(1):96-98. doi: 10.23736/S0392-0488.17.05673-5. G Ital Dermatol Venereol. 2019. PMID: 30616337 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters